Clinical quality assurance for 106Ru ophthalmic applicators.

@article{Kaulich2005ClinicalQA,
  title={Clinical quality assurance for 106Ru ophthalmic applicators.},
  author={Theodor W. Kaulich and Jens Zurheide and Thomas Haug and Fridtjof N{\"u}sslin and Michael Bamberg},
  journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  year={2005},
  volume={76 1},
  pages={
          86-92
        }
}
BACKGROUND AND PURPOSE Episcleral brachytherapy using 106Ru/106Rh ophthalmic applicators is a proven method of therapy of uveal melanomas sparing the globe and in many cases sparing the vision. In the year 2001, an internal clinical quality assurance procedure revealed that part of the ophthalmic applicators leaked and that the calibration was erroneous. Consequently, the producer modernized its production procedures and, in May 2002, introduced a dose rate calibration that is traceable to the… CONTINUE READING